These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7311186)

  • 1. The usefulness and limitations of CEA assay in the management of colorectal cancer.
    Tomoda H; Furusawa M
    Jpn J Surg; 1981 Jan; 11(1):33-8. PubMed ID: 7311186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
    Wanebo JH; Stearns M; Schwartz MK
    Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
    Metzger U; Decurtins M; Joller H; Grob PJ; Largiadèr F
    Schweiz Med Wochenschr; 1983 Apr; 113(15):548-9. PubMed ID: 6857209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
    Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
    Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.
    Goslin R; Steele G; Macintyre J; Mayer R; Sugarbaker P; Cleghorn K; Wilson R; Zamcheck N
    Ann Surg; 1980 Dec; 192(6):747-51. PubMed ID: 7447529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.
    Tomoda H; Furusawa M
    Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of CEA in postoperative monitoring of colorectal cancers].
    Cossu F; Fodde M; Ledda P; Pisano G; Rombi GP; Scintu F; Tuveri A
    Minerva Med; 1984 Oct; 75(40):2373-80. PubMed ID: 6504398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.
    Martin EW; Minton JP; Carey LC
    Ann Surg; 1985 Sep; 202(3):310-7. PubMed ID: 4037904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
    Arnaud JP; Koehl C; Adloff M
    Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.